Compare Fiverr International Ltd (FVRR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs GeneDx Holdings Corp — how do they compare? Fiverr International Ltd trades at $8.72 (market cap $310.61M), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 6.5× Fiverr International Ltd's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and GeneDx Holdings Corp for 19 Days on average.
| FVRR | WGS | |
|---|---|---|
Market Cap | $310.61M | $2.02B |
Volume | 381,459 | 734,640 |
Sector | Media | Health |
52-Week High | $23.60 | $167.51 |
52-Week Low | $8.47 | $34.51 |
Typical Hold Time | 62 Days | 19 Days |
Enterprise Value | $63.00M | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.64, up 1.65% on the day, amid a bearish technical outlook with recent earnings misses in Q1 and Q2 2026. Revenue for 2025 reached $430.91M with a net income margin of 7.18%, though 2026 revenue is projected to dip to $418M. Valuation ratios appear attractive with a P/E of 10.67 and P/S of 0.76, but the stock faces headwinds from AI disruption compressing demand for freelance services, as highlighted in recent news.
The stock's outlook is cautious, with analyst consensus leaning Hold (76.47%) and a price target of $10.50 offering potential upside. Key risks include AI-driven market shifts and competitive pressures, while the current low valuation may appeal to value investors if the company navigates transitional challenges successfully.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
